drugset / Trial / NCT00168441
A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia
RandomizedParallel-groupDouble-blindTreatment
Summary
4-month study including a 30-day baseline phase
Timeline
- Start
- 2004-06
- Primary completion
- 2005-06
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |